Opioid Treatment Episodes

Dr. Natasha Bagdasarian, ASTHO member and chief medical executive for the State of Michigan, explains how Michigan’s multifaceted approach has reduced overdose deaths across the state; Heidi Westermann, director of public health data modernization and informatics at ASTHO...

Dr. Kaitlan Baston, ASTHO alum and the former New Jersey commissioner of health, reflects on her time in the role as she steps down; Dr. Hang Lu, assistant professor in the department of communication and media at the University of Michigan, discusses an...

Dr. Kaitlan Baston, former commissioner of health for the New Jersey Department of Health and ASTHO alumni, outlines what New Jersey has been doing to address opioids; Kate Murray, program supervisor for Long COVID and post-COVID conditions at the...

Allison Wheeler, wastewater surveillance unit manager at the Colorado Department of Public Health and Environment, and co-director of the Wastewater Center of Excellence in Colorado, tells us about a recently published ASTHO report on ethical considerations in public health wastewater surveillance;…

Dr. Mark Levine, commissioner of health for the State of Vermont and an ASTHO Member, looks back on his time as commissioner as he gets ready to depart his post; Melissa Touma, ASTHO director of the Public Health Infrastructure Program, tells us how a...

Dr. Heidi B. Miller, chief medical officer of the Missouri Department of Health and Senior Services, explains how her state was able to see the first significant decline in drug overdose deaths in nearly a decade; Jeffrey Ekoma, ASTHO senior director...

Dr. Kelly S. Ramsey, an addiction medicine and harm reduction consultant, discusses a Q&A she wrote for Johns Hopkins about the expansion of methadone treatment access; Matta Sannoh, ASTHO chronic disease risk factors senior analyst, tells us...